Lizhou Zhang

Hivatkozott rá

	Összes	2020 óta
Hivatkozások	3109	2928
h-index	19	17
i10-index	23	19

940

470

235

705

2015201620172018201920202021202220232024202519 27 36 35 47 386 932 718 445 355 58

Nyilvános hozzáférés

Összes megtekintése

20 cikk

5 cikk

elérhető

nem érhető el

Finanszírozási megbízások alapján

Társszerzők

Hyeryun ChoeBoston Children's Hospital, Harvard Medical SchoolE-mail megerősítve itt: childrens.harvard.edu
Michael FarzanProfessor of Pediatrics, Harvard Medical SchoolE-mail megerősítve itt: childrens.harvard.edu
Cody B JacksonBoston Children's Hospital, Harvard Medical SchoolE-mail megerősítve itt: childrens.harvard.edu
Haiyong PengThe Scripps Research Institute, FloridaE-mail megerősítve itt: scripps.edu
Christoph RaderChief Technology Officer, Aethon Therapeutics, Inc.E-mail megerősítve itt: aethontx.com
Wenhui LiNational Institute of Biological Sciences,BeijingE-mail megerősítve itt: nibs.ac.cn
Wenhui HePIE-mail megerősítve itt: cimrbj.ac.cn
Mehul S. SutharAssociate Professor Emory UniversityE-mail megerősítve itt: emory.edu
Abigail VanderheidenPostdoctoral Scholar, Washington University in St. LouisE-mail megerősítve itt: wustl.edu
Tianling OuBroad InstituteE-mail megerősítve itt: broadinstitute.org
GUOCAI ZHONGAssistant Professor (PI), UMass Medical SchoolE-mail megerősítve itt: umassmed.edu
Mark ParcellsProfessor of Virology, University of DelawareE-mail megerősítve itt: udel.edu
Gogce Ceren CrynenThe Herbert Wertheim UF Scripps Institute for Biomedical Innovation & TechnologyE-mail megerősítve itt: ufl.edu
Qi WangChengdu National Agricultural Science and Technology Center，Chinese Academy of Agricultural SciencesE-mail megerősítve itt: email.unc.edu
Shoujiao PengShanghai University of Traditional Chinese MedicineE-mail megerősítve itt: shutcm.edu.cn
Norbert PardiUniversity of PennsylvaniaE-mail megerősítve itt: mail.med.upenn.edu
Rubens TavoraScripps ResearchE-mail megerősítve itt: scripps.edu
Qiang ChenUniversity of Pittsburgh, School of MedcineE-mail megerősítve itt: pitt.edu
Dr. Michaela GackScientific Director and Chair, Cleveland Clinic Florida Research and Innovation CenterE-mail megerősítve itt: ccf.org
GuanQun LiuDepartment of Microbiology & Immunology, McGill UniversityE-mail megerősítve itt: mcgill.ca

Követés

Lizhou Zhang

Boston Children's Hospital, Harvard Medical School

E-mail megerősítve itt: childrens.harvard.edu

RNA Virus Entry (Flavivirus SARS-CoV-2 etc)Vaccine mRNA-LNP Therapeutics AAV Delivery


Cím Rendezés hivatkozások szerint Rendezés év szerint Rendezés cím szerint	Hivatkozott rá Hivatkozott rá	Év
SARS-CoV-2 spike-protein D614G mutation increases virion spike density and infectivity L Zhang, CB Jackson, H Mou, A Ojha, H Peng, BD Quinlan, ... Nature communications 11 (1), 1-9, 2020	1538*	2020
A single immunization with nucleoside-modified mRNA vaccines elicits strong cellular and humoral immune responses against SARS-CoV-2 in mice D Laczkó, MJ Hogan, SA Toulmin, P Hicks, K Lederer, BT Gaudette, ... Immunity 53 (4), 724-732. e7, 2020	371	2020
Hydroxychloroquine-mediated inhibition of SARS-CoV-2 entry is attenuated by TMPRSS2 T Ou, H Mou, L Zhang, A Ojha, H Choe, M Farzan PLoS pathogens 17 (1), e1009212, 2021	231	2021
An engineered receptor-binding domain improves the immunogenicity of multivalent SARS-CoV-2 vaccines Y Guo, W He, H Mou, L Zhang, J Chang, S Peng, A Ojha, R Tavora, ... Mbio 12 (3), 10.1128/mbio. 00930-21, 2021	177*	2021
Functional importance of the D614G mutation in the SARS-CoV-2 spike protein CB Jackson, L Zhang, M Farzan, H Choe Biochemical and Biophysical Research Communications 538, 108-115, 2021	117	2021
Effect of mRNA-LNP components of two globally-marketed COVID-19 vaccines on efficacy and stability L Zhang, KR More, A Ojha, CB Jackson, BD Quinlan, H Li, W He, ... npj Vaccines 8 (1), 156, 2023	71	2023
Mutations of residues 249 and 256 in VP2 are involved in the replication and virulence of infectious bursal disease virus X Qi, L Zhang, Y Chen, L Gao, G Wu, L Qin, Y Wang, X Ren, Y Gao, ... Plos one 8 (7), e70982, 2013	64	2013
Mutations derived from horseshoe bat ACE2 orthologs enhance ACE2-Fc neutralization of SARS-CoV-2 H Mou, BD Quinlan, H Peng, G Liu, Y Guo, S Peng, L Zhang, ... PLoS pathogens 17 (4), e1009501, 2021	60*	2021
The D614G mutation in the SARS-CoV-2 spike protein reduces S1 shedding and increases infectivity. bioRxiv 2020 L Zhang, CB Jackson, H Mou, A Ojha, ES Rangarajan, T Izard, M Farzan, ... Academic Search, 0	54
Naturally occurring reassortant infectious bursal disease virus in northern China Z Lu, L Zhang, N Wang, Y Chen, L Gao, Y Wang, H Gao, Y Gao, K Li, X Qi, ... Virus research 203, 92-95, 2015	53	2015
Molecular characterization and phylogenetic analysis of the reticuloendotheliosis virus isolated from wild birds in Northeast China L Jiang, X Qi, Y Gao, Y Hua, K Li, X Deng, Q Wang, L Zhang, H Chai, ... Veterinary microbiology 166 (1-2), 68-75, 2013	47	2013
First isolation of reticuloendotheliosis virus from mallards in China L Jiang, X Deng, Y Gao, K Li, H Chai, Z Fan, X Ren, Q Wang, L Zhang, ... Archives of virology 159, 2051-2057, 2014	31	2014
Phosphatidylethanolamine and phosphatidylserine synergize to enhance GAS6/AXL-mediated virus infection and efferocytosis L Zhang, AS Richard, CB Jackson, A Ojha, H Choe Journal of virology 95 (2), 10.1128/jvi. 02079-20, 2020	30	2020
Infectious bursal disease virus subverts autophagic vacuoles to promote viral maturation and release Y Wang, Y Duan, C Han, S Yao, X Qi, Y Gao, HJ Maier, P Britton, L Chen, ... Journal of Virology 91 (5), 10.1128/jvi. 01883-16, 2017	30	2017
Voltage-dependent anion channel 1 interacts with ribonucleoprotein complexes to enhance infectious bursal disease virus polymerase activity C Han, X Zeng, S Yao, L Gao, L Zhang, X Qi, Y Duan, B Yang, Y Gao, ... Journal of virology 91 (16), 10.1128/jvi. 00584-17, 2017	28	2017
Genomic sequencing and molecular characteristics of a very virulent strain of infectious bursal disease virus isolated in China. QXL Qi XiaoLe, GL Gao Li, QLT Qin LiTing, DXY Deng XiaoYun, ...	27	2011
The SARS-CoV-2 receptor-binding domain elicits a potent neutralizing response without antibody-dependent enhancement. bioRxiv. 2020 BD Quinlan, H Mou, L Zhang, Y Guo, W He, A Ojha, MS Parcells, G Luo, ... Preprint, 0	26
Ribosomal protein L4 interacts with viral protein VP3 and regulates the replication of infectious bursal disease virus Y Chen, Z Lu, L Zhang, L Gao, N Wang, X Gao, Y Wang, K Li, Y Gao, ... Virus Research 211, 73-78, 2016	25	2016
A single mutation in the P_BC loop of VP2 is involved in the in vitro replication of infectious bursal disease virus X Qi, X Gao, Z Lu, L Zhang, Y Wang, L Gao, Y Gao, K Li, H Gao, C Liu, ... Science China Life Sciences 59, 717-723, 2016	21	2016
Cyclophilin A interacts with viral VP4 and inhibits the replication of infectious bursal disease virus N Wang, L Zhang, Y Chen, Z Lu, L Gao, Y Wang, Y Gao, H Gao, H Cui, ... BioMed Research International 2015 (1), 719454, 2015	17	2015

A rendszer jelenleg nem tudja elvégezni a műveletet. Próbálkozzon újra később.

Cikkek 1–20

Hivatkozások évente

Ismétlődő hivatkozások

Összevont hivatkozások

Társszerzők hozzáadásaTársszerzők

Követés

Hivatkozott rá

Társszerzők